Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2007

Published online before print October 17, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0506298v1
81/3/607    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sireci, G.
Right arrow Articles by Salerno, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sireci, G.
Right arrow Articles by Salerno, A.
Related Collections
Right arrowRelated Article
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0506298


Received for publication April 28, 2006.
Revised June 16, 2006.
Accepted for publication August 1, 2006.


Article

{alpha}-Galactosylceramide induces protection against lipopolysaccharide-induced shock

Guido Sireci *@, Marco P. La Manna *, Caterina Di Sano {dagger}, Diana Di Liberto *, Steven A. Porcelli {ddagger}, Mitch Kronenberg {sect}, Francesco Dieli *, and Alfredo Salerno *

*Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Palermo, Italy; {dagger}Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Palermo, Italy; {ddagger}Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA; and {sect}La Jolla Institute for Allergy and Immunology, San Diego, Calfornia, USA

@ To whom correspondence should be addressed. E-mail: sireci{at}unipa.it.


   Abstract

{alpha}-galactosylceramide, a natural killer T cell ligand, and its synthetic homologue, KRN7000, consistently influence IFN-{gamma} and TNF-{alpha} release, both mediators of LPS-induced shock. To modify the course of endotoxin shock, we injected KRN7000 at different time points of experimental systemic Shwartzmann reaction. Mice treated with KRN7000 survived when it was injected within 2 h before and after LPS challenge. Mice survival was associated with low levels of T helper 1 (Th1) cytokines, such as IFN-{gamma} and TNF-{alpha}. By contrast, protection from endotoxin shock was associated with an increase of T helper 2 (Th2) cytokines, like IL-4 and IL-10. A role of Th2 cytokines in counteracting LPS-induced shock was supported by experiments in which the protection against Shwartzmann reaction by KRN7000 was abrogated by in vivo coadministration of anti-Th2 cytokines antibodies. In addition, cytofluorimetric analysis showed that surviving animals have higher percentages of NKT-IL-10-positive cells and lower percentages of NKT-IFN-{gamma} and macrophages/TNF-{alpha}-stained cells than nonprotected mice. Taken together, our data demonstrate that KRN7000 treatment given at times near LPS challenge is protective for endotoxin shock inhibiting IFN-{gamma} and TNF-{alpha} release. Moreover, KRN7000-mediated protection occurs through an increased production of IL-4 and IL-10, which are mainly secreted by NKT cells. Since IFN-{gamma} release by NKT requires a longer TCR stimulation than that required for Th2 cytokines production, we demonstrate that timing of KRN7000 in vivo exposure affect the pattern of cytokines expression protecting animals by endotoxin shock.

Key Words: rodent • cytokines


Related Article

The Shwartzman reaction repealed
Helene F. Rosenberg
J. Leukoc. Biol. 2007 81: 623-624. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
G. Sireci, M. P. La Manna, D. Di Liberto, M. Lo Dico, M. Taniguchi, F. Dieli, and A. Salerno
Prophylaxis of lipopolysaccharide-induced shock by {alpha}-galactosylceramide
J. Leukoc. Biol., August 1, 2008; 84(2): 550 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. M. Kattan, F. B. Kasravi, E. L. Elford, M. T. Schell, and H. W. Harris
Apolipoprotein E-Mediated Immune Regulation in Sepsis
J. Immunol., July 15, 2008; 181(2): 1399 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Biburger and G. Tiegs
Activation-induced NKT cell hyporesponsiveness protects from {alpha}-galactosylceramide hepatitis and is independent of active transregulatory factors
J. Leukoc. Biol., July 1, 2008; 84(1): 264 - 279.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. O. Etogo, J. Nunez, C. Y. Lin, T. E. Toliver-Kinsky, and E. R. Sherwood
NK but Not CD1-Restricted NKT Cells Facilitate Systemic Inflammation during Polymicrobial Intra-Abdominal Sepsis
J. Immunol., May 1, 2008; 180(9): 6334 - 6345.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Garlanda, D. Di Liberto, A. Vecchi, M. P. La Manna, C. Buracchi, N. Caccamo, A. Salerno, F. Dieli, and A. Mantovani
Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling
J. Immunol., September 1, 2007; 179(5): 3119 - 3125.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.